Japanese Encephalitis Vaccines

Known as: Japanese encephalitis, Japanese Encephalitis vaccine, unspecified formulation, Japanese Encephalitis Vaccines [Chemical/Ingredient] 
Vaccines or candidate vaccines used to prevent infection with Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE).
National Institutes of Health

Topic mentions per year

Topic mentions per year

1947-2018
020406019472017

Related topics

Related topics

9 relations
In BloodJapanese B encephalitis vaccine (product)Japanese EncephalitisProcess of secretion
(More)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Japanese Encephalitis Vaccines
standards characteristics
chemical synthesis
Japanese Encephalitis
agonists
In Blood

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Japanese Encephalitis Vaccines.
Japanese encephalitis (JE) is a significant human health concern in Asia, Indonesia and parts of Australia with more than 3… (More)
  • table 1
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO®]
▴ The Japanese encephalitis vaccine IC-51 (IXIARO®) is an inactivated virus (strain SA14-14-2) that is manufactured in cultured… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to…
ChimeriVax-JE is a live, attenuated vaccine against Japanese encephalitis, using yellow fever (YF) 17D vaccine as a vector. In a… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.
OBJECTIVE We conducted a prospective study among Japanese Americans of diabetes incidence in relation to visceral and regional… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.
Japanese encephalitis (JE) is a leading cause of viral encephalitis in Asia that, in several countries, has been controlled… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the…
BACKGROUND A high proportion of U.S. patients with gastric carcinoma do not receive surgical treatment. To sharpen staging… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
The peroxisome proliferator-activated receptor-γ (PPARγ) is a transcription factor that has a pivotal role in adipocyte… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.
BACKGROUND Helicobacter pylori are gram-negative spiral bacteria that are associated with chronic gastritis, a known precursor of… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Protection against Japanese encephalitis by inactivated vaccines.
Encephalitis caused by Japanese encephalitis virus occurs in annual epidemics throughout Asia, making it the principal cause of… (More)
Is this relevant?